US 7261900
Recombinant modified Bacillus anthracis protective antigen for use in vaccines
granted A61KA61K2039/505A61K2039/53
Quick answer
US patent 7261900 (Recombinant modified Bacillus anthracis protective antigen for use in vaccines) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K2039/53, A61K39/00, A61P